181 related articles for article (PubMed ID: 31115051)
41. E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity.
Druzhkova I; Ignatova N; Prodanets N; Kiselev N; Zhukov I; Shirmanova M; Zagainov V; Zagaynova E
Clin Colorectal Cancer; 2019 Mar; 18(1):e74-e86. PubMed ID: 30415989
[TBL] [Abstract][Full Text] [Related]
42. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
[TBL] [Abstract][Full Text] [Related]
43. Treatment of cancer stem cells from human colon adenocarcinoma cell line HT-29 with resveratrol and sulindac induced mesenchymal-endothelial transition rate.
Pouyafar A; Rezabakhsh A; Rahbarghazi R; Heydarabad MZ; Shokrollahi E; Sokullu E; Khaksar M; Nourazarian A; Avci ÇB
Cell Tissue Res; 2019 Jun; 376(3):377-388. PubMed ID: 30758710
[TBL] [Abstract][Full Text] [Related]
44. Effect of gastric cancer stem cell on gastric cancer invasion, migration and angiogenesis.
Zhu Z; Xu J; Li L; Ye W; Xu G; Chen B; Zeng J; Li J; Huang Z
Int J Med Sci; 2020; 17(13):2040-2051. PubMed ID: 32788883
[No Abstract] [Full Text] [Related]
45. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
[TBL] [Abstract][Full Text] [Related]
46. Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy.
Yang S; Zheng J; Ma Y; Zhu H; Xu T; Dong K; Xiao X
Oncol Rep; 2012 Jul; 28(1):186-92. PubMed ID: 22576801
[TBL] [Abstract][Full Text] [Related]
47. Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy.
Rad SM; Bamdad T; Sadeghizadeh M; Arefian E; Lotfinia M; Ghanipour M
Tumour Biol; 2015 Apr; 36(4):2621-9. PubMed ID: 25464862
[TBL] [Abstract][Full Text] [Related]
48. Development and gene expression of porcine cloned embryos derived from bone marrow stem cells with overexpressing Oct4 and Sox2.
Lee JH; Lee WJ; Jeon RH; Lee YM; Jang SJ; Lee SL; Jeon BG; Ock SA; King WA; Rho GJ
Cell Reprogram; 2014 Dec; 16(6):428-38. PubMed ID: 25437870
[TBL] [Abstract][Full Text] [Related]
49. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
Ikushima H; Todo T; Ino Y; Takahashi M; Saito N; Miyazawa K; Miyazono K
J Biol Chem; 2011 Dec; 286(48):41434-41441. PubMed ID: 21987575
[TBL] [Abstract][Full Text] [Related]
50. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
51. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
52. Folate Receptor Alpha Upregulates Oct4, Sox2 and Klf4 and Downregulates miR-138 and miR-let-7 in Cranial Neural Crest Cells.
Mohanty V; Shah A; Allender E; Siddiqui MR; Monick S; Ichi S; Mania-Farnell B; G McLone D; Tomita T; Mayanil CS
Stem Cells; 2016 Nov; 34(11):2721-2732. PubMed ID: 27300003
[TBL] [Abstract][Full Text] [Related]
53. Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.
Mistri TK; Devasia AG; Chu LT; Ng WP; Halbritter F; Colby D; Martynoga B; Tomlinson SR; Chambers I; Robson P; Wohland T
EMBO Rep; 2015 Sep; 16(9):1177-91. PubMed ID: 26265007
[TBL] [Abstract][Full Text] [Related]
54. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
55. Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells.
Han SM; Han SH; Coh YR; Jang G; Chan Ra J; Kang SK; Lee HW; Youn HY
Exp Mol Med; 2014 Jun; 46(6):e101. PubMed ID: 24946789
[TBL] [Abstract][Full Text] [Related]
56. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
Wang T; Li QH; Hao GP; Zhai J
Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
[TBL] [Abstract][Full Text] [Related]
57. Application of Transcription Factor Decoy Oligodeoxynucleotides (ODNs) for Cancer Therapy.
Johari B; Moradi M
Methods Mol Biol; 2022; 2521():207-230. PubMed ID: 35733000
[TBL] [Abstract][Full Text] [Related]
58. Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis.
Lee JH; Yun CW; Han YS; Kim S; Jeong D; Kwon HY; Kim H; Baek MJ; Lee SH
J Pineal Res; 2018 Nov; 65(4):e12519. PubMed ID: 30091203
[TBL] [Abstract][Full Text] [Related]
59. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
60. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
You L; Guo X; Huang Y
Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
